perphenazine 16 mg
INDICATIONS AND USAGE Perphenazine tablets, USP are indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine tablets, USP have not been shown effective for the management of behavioral complications in patients with mental retardation.
cadila healthcare limited
ROUND WHITE 594
Related Pills
perphenazine 2 mg
cadila healthcare limited
perphenazine 8 mg
cadila healthcare limited
perphenazine 4 mg
cadila healthcare limited
atomoxetine 60 MG Oral Capsule
Teva Pharmaceuticals USA, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
HOW SUPPLIED
PERPHENAZINE Tablets USP, 2 mg are white to off white, round, biconvex, film coated tablet debossed with '5' on one side and '91' on other side and are supplied as follows: NDC 70771-1041-1 in bottles of 100 tablets NDC 70771-1041-5 in bottles of 500 tablets NDC 70771-1041-4 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets
PERPHENAZINE Tablets USP, 4 mg are white to off white, round, biconvex, film coated tablet debossed with '592' on one side and plain on other side and are supplied as follows: NDC 70771-1042-1 in bottles of 100 tablets NDC 70771-1042-5 in bottles of 500 tablets NDC 70771-1042-4 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets
PERPHENAZINE Tablets USP, 8 mg are white to off white, round, biconvex, film coated tablet debossed with '593' on one side and plain on other side and are supplied as follows: NDC 70771-1043-1 in bottles of 100 tablets NDC 70771-1043-5 in bottles of 500 tablets NDC 70771-1043-4 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets
PERPHENAZINE Tablets USP, 16 mg are white to off white, round, biconvex, film coated tablet debossed with '594' on one side and plain on other side and are supplied as follows: NDC 70771-1044-1 in bottles of 100 tablets NDC 70771-1044-5 in bottles of 500 tablets NDC 70771-1044-4 in unit-dose blister cartons of 100 (10 x 10) unit-dose tablets Storage Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature] . Dispense in a tight, light-resistant container (USP). Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. Manufactured by: Zydus Lifesciences Ltd., Baddi, India Rev.: 11/24
More pills like ROUND 594